Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-10-06Gaining Insights Into Patient Involvement Patterns and Trends in Participation in Lymphoma Clinical Trials
-
CLINICAL_TRIALS study record update · 2023-10-06A Phase II Trial Of BEAM/Rituximab/Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Patients With CD20 Positive Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2023-09-29Medical Professor,CHONGQING UNIVERSITY CANCER HOSPITAL
-
CLINICAL_TRIALS study record update · 2023-09-28An Intention-to-Treat Study of Salvage Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of High-Risk or Relapsed Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2023-09-22A Phase I, Open-Label, Single Institution Study to Assess the Safety, Tolerability, and Pharmacokinetics of Durvalumab in Pediatric Patients With Relapsed or Refractory Solid Tumors, Lymphoma, and Central Nervous System Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-09-21A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VP301 in Patients With Relapsed or Refractory Multiple Myeloma, Lymphoma, or Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-09-21Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
-
CLINICAL_TRIALS study record update · 2023-09-21Quality of Life in Lymphoma Patients and Cancer Care Pathway One Year Post-chemotherapy
-
CLINICAL_TRIALS study record update · 2023-09-15Value of Chemokine Receptor CXCR4-targeting Molecular Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
-
CLINICAL_TRIALS study record update · 2023-09-07Clinical Study on the Effectiveness and Safety of PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells for Lymphoma and Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2023-09-07A Phase I/II Trial of Rituxan and BEAM High-Dose Chemotherapy and Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma
-
CLINICAL_TRIALS study record update · 2023-09-07A Phase II Trial to Evaluate the Rate of Immune Response Using Idiotype Immunotherapies Produced by Molecular Biological Means for Treatment of Aggressive B Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2023-09-06A Phase 1 Study of JS014, a Recombinant Fusion Protein of Interleukin-21 and Humanized Anti-human Serum Albumin VHH Antibody as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2023-09-01BEAM Plus Iodine-131 Anti-B1 Antibody and Autologous Hematopoietic Stem Cell Transplantation for Treatment of Recurrent Diffuse Large B-Cell Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2023-09-01A Phase II Trial of Rituxan and BEAM High-Dose Chemotherapy and Autologous Peripheral Blood Progenitor Transplant for Lymphoma
-
CLINICAL_TRIALS study record update · 2023-08-28A Pilot Clinical Trial of Autologous EphA-2-Targeting Chimeric Antigen Receptor Dendritic Cell Vaccine Loaded With TP53 Mutant Peptide Plus ICIs for Local Advanced/Metastatic Solid Tumors or Relapsed/Refractory Lymphomas.
-
CLINICAL_TRIALS study record update · 2023-08-28Pilot Study on the Infusion of Differentiated Autologous T-cells From Peripheral Blood, Expanded and Transduced With a Lentivirus to Express a Chimeric Antigen Receptor With Anti-CD19 Specificity Conjugated With the Co-stimulatory Regions 4-1BB and CD3z in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy
-
CLINICAL_TRIALS study record update · 2023-08-23Evaluation Study of Fear of Cancer Recurrence: Detection, Measure and Risk Factors in Lymphoma Survivorship
-
CLINICAL_TRIALS study record update · 2023-08-14T Cell-Reduced Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation With Pentostatin and Low-Dose Total Body Irradiation
-
CLINICAL_TRIALS study record update · 2023-08-14A Phase 1b, Open-Label, Dose-Escalation Study for the Safety, Tolerability, and Pharmacokinetics of INCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111)
-
CLINICAL_TRIALS study record update · 2023-08-08A Phase I/II Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Initial Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Patients With Locally Advanced/Metastatic Solid Tumors or Lymphoma
-
CLINICAL_TRIALS study record update · 2023-08-08Effectiveness of Integrative Medicine Treatments in Lymphoma Survivors
-
CLINICAL_TRIALS study record update · 2023-08-04A Phase I Study of AT7519M Given Twice Weekly in Patients With Advanced Incurable Malignancy
-
CLINICAL_TRIALS study record update · 2023-08-04A Phase II Study of Bortezomib and Gemcitabine in Patients With Relapsed Mantle Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2023-08-04A Phase II Study Of PS-341 (NSC 681239) In Patients With Untreated Or Relapsed Mantle Cell Lymphoma